MAPT and tauopathy: To investigate the efficacy of ISO in inhibiting tau aggregation and subsequent neuronal loss in a relevant animal model of tauopathy, we used a transgenic mouse line that expresses a highly aggregating form of tau, encoded by the human P301L tau gene.